z-logo
open-access-imgOpen Access
Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening
Author(s) -
Tanja Vollmer,
Cornelius Knabbe,
J Dreier
Publication year - 2016
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000450794
Subject(s) - medicine , virology , hepatitis virus , blood donor , hepatitis c virus , intensive care medicine , virus , hepatitis , immunology , medical emergency
Recently, Hewitt et al. [1] demonstrated transmission of hepatitis E viruses (HEV) via contaminated blood in 42% of transfusion recipients. The authors reported a prevalence rate of 1:2,848 HEV RNA-positive donors in England, a figure comparable to other European countries (Germany 1:1,240 [2], The Netherlands 1:1,761 [3]). In industrial countries, chronic, severe, or fatal HEV infections have been observed in immunosuppressed individuals (e.g. transplant patients, hematological patients [4]) and in individuals with pre-existing liver diseases [5,6].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom